Head and Neck Cancer New Indication: Enfortumab Vedotin for Head and Neck Cancer Ulas D. Bayraktar, MD 2025-03-02
Head and Neck Cancer New Indication: Axitinib and Avelumab for Adenoid Cystic Carcinoma Ulas D. Bayraktar, MD 2023-04-14
Head and Neck Cancer New Indicaiton: DOCEtaxel as a Radiosensitizer in Head and Neck Cancer Ulas D. Bayraktar, MD 2023-03-15
